Publication bias in clinical trials (Protocol) by Loudon, Kirsty et al.
Publication bias in clinical trials (Protocol)
Olsen KL, Hopewell S, Dickersin K, Clarke M, Oxman AD
This is a reprint of a Cochrane protocol, prepared and maintained by The Cochrane Collaboration and published in The Cochrane
Library 2001, Issue 3
http://www.thecochranelibrary.com
Publication bias in clinical trials (Protocol)
Copyright © 2007 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
T A B L E O F C O N T E N T S
1ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1BACKGROUND . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1OBJECTIVES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1CRITERIA FOR CONSIDERING STUDIES FOR THIS REVIEW . . . . . . . . . . . . . . . . . .
2SEARCH METHODS FOR IDENTIFICATION OF STUDIES . . . . . . . . . . . . . . . . . . .
2METHODS OF THE REVIEW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3POTENTIAL CONFLICT OF INTEREST . . . . . . . . . . . . . . . . . . . . . . . . . . .
3ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4SOURCES OF SUPPORT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4COVER SHEET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
iPublication bias in clinical trials (Protocol)
Copyright © 2007 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd
Publication bias in clinical trials (Protocol)
Olsen KL, Hopewell S, Dickersin K, Clarke M, Oxman AD
This record should be cited as:
Olsen KL, Hopewell S, Dickersin K, Clarke M, Oxman AD. Publication bias in clinical trials. (Protocol) Cochrane Database of
Methodology Reviews 2001, Issue 3. Art. No.: MR000006. DOI: 10.1002/14651858.MR000006.
This version first published online: 23 July 2001 in Issue 3, 2001.
Date of most recent substantive amendment: 25 May 2001
A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
To summarise evidence of publication bias for trials of health care interventions.
B A C K G R O U N D
Completed research is frequently left unpublished (Dickersin
1990). It has been suggested that in the case of research conducted
on humans, failure to publish represents scientific misconduct,
since individuals who consent to participate in research, and agen-
cies that provide funding support for investigations, do so with the
understanding that the work will make a contribution to knowl-
edge (Chalmers 1990). Clearly, knowledge that is not dissemi-
nated is not making a “contribution”.
Failure to publish is not only inappropriate scientific conduct;
it also influences the information available for interpretation by
the scientific community. If research is left randomly unpub-
lished, there is less information available, but that information is
not necessarily biased. The tendency for investigators to submit
manuscripts and of editors and reviewers to accept them, based on
the strength and direction of the research findings, has been de-
fined as publication bias (Chalmers 1990, Dickersin 1990, Dick-
ersin 1997).
Song et al (Song 2000) also suggested that this termmight include
biases related to time, the type and language of publication, mul-
tiple publication and selective citation of references. They suggest
that dissemination bias may be a better expression with which to
replace this broad use of the term for selective publication.
Publication bias in health care has been discussed for many years
(Dickersin 1987, Simes 1986, Simes 1987) and those who carry
out systematic reviews need to identify as unbiased and complete
a set of relevant studies as possible for inclusion in their review;
otherwise the conclusions could potentially be biased and therefore
may be invalid.
Three ways to minimise the effect of publication bias on a sys-
tematic review were outlined by Song et al. First, by accessing a
register of prospective trials when undertaking a systematic review,
secondly by seeking to detect publication bias during a review (for
example by locating unpublished studies) and thirdly, by reducing
the impact of publication bias by updating the review when tri-
als become available or undertaking confirmatory large-scale trials
(Song 2000).
This systematic review of methodology is the update of an original
meta-analysis by one of the authors (KD), which aims to assess
the evidence of publication bias in a series of cohorts of registered
studies (Dickersin 1992, Dickersin 1993, Dickersin 1997, East-
erbrook 1991, Stern 1996, Stern 1997).
O B J E C T I V E S
To summarise evidence of publication bias for trials of health care
interventions.
C R I T E R I A F O R C O N S I D E R I N G
S T U D I E S F O R T H I S R E V I E W
Types of studies
Cohorts of trials “registered” (i.e. trials entered into a formal
database or some other list such as for submissions to an Insti-
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tutional Review Board or a prospective trials register) at onset or
while ongoing, but prior to the main results being known.
Types of data
Must be either a complete series of trials (e.g. all registered during a
specified time period) or an unbiased sample (e.g. random sample)
of trials. Studies are accepted as clinical trials if they are so defined
by the study authors, involve the testing of a health care interven-
tion and include people as participants. Studies that include non-
trial research are eligible for the review, if data specifically related
to clinical trials are available and are able to be analysed separately
from the non-trials. If these results cannot be separated using the
information in the published report, attempts will be made to ob-
tain the data from the study investigators. The primary analysis
will be based on an assessment of trials comparing a standard in-
tervention (as defined by the trialists) versus a new or experimental
intervention.
Types of comparisons
The publication rate of trials with positive findings will be com-
pared to the publication rate of those with “negative” findings,
based on the p-value (<0.05 versus >0.05 respectively, unless oth-
erwise specified).We will also compare the publication rate of pos-
itive versus negative trials by considering the direction of effect
and the magnitude of effect. Positive findings are defined as those
with statistically significant results (p<0.05) in favour of the exper-
imental arm of the trial. “Negative” findings are broadly defined as
those with non-statistically significant results (p>0.05) or results
in favour of the control arm. Statistically significant findings in
favour of the control arm and non-statistically significant results
will be considered separately, although “negative” findings is used
to refer to both. If sufficient data are available, other factors that
may be associated with failure to publish will be examined. These
include study quality, number of study groups, source of funding,
sample size, number of clinical centres, and investigator rank and
sex.
Types of outcome measures
The primary outcomes will be publication and time from com-
pletion of research (end of data collection) to full publication in a
journal. Secondary outcomeswill include whether or not the study
results were written up, reasons for failure to publish, publication
in English versus other languages, publications indexed in MED-
LINE versus non-MEDLINE, and different types of publication
(e.g. grey literature, including in-house publications and theses).
These outcomes will be reported by study findings (positive versus
negative).
S E A R C H M E T H O D S F O R
I D E N T I F I C A T I O N O F S T U D I E S
See: methods used in reviews.
The Cochrane Methodology Register will be searched using
the index term “publication bias” including language bias and
duplicate publication bias. MEDLINE and PREMEDLINE will
be searched using OVID with the following terms:
#1 Publication Bias (MeSH)
#2 Exp. Publications (MeSH) OR publication$ (text word) OR
publishing (MeSH) OR publish$ (text word)
#3 Exp. bias (epidemiology) (MeSH) OR bias (text word)
#4 2 and 3
#5 1 or 4
We will also search for “related articles” in MEDLINE for studies
that meet the inclusion criteria. EMBASE will be searched using
OVID with the following terms:
#1 Publishing (EMTREE) OR Publishing (text word)
#2 Publication (EMTREE) OR Publication (text word)
#3 Bias (text word)
#4 1 or 2
#5 3 and 4
We will search SciSearch, using articles deemed eligible for the
review, to identify additional articles that cite studies that meet
our inclusion criteria. Finally we will contact methodologists and
authors of key studies on publication bias to try and identify
further studies. We will check reference lists of relevant articles to
identify references to possible relevant citations.
M E T H O D S O F T H E R E V I E W
Identifying studies
One reviewer (KLO) will screen the titles and abstracts of all
retrieved records to identify obvious exclusions. A second reviewer
(SH) will check the exclusion of other less obvious records, before
rejection. Any disagreements will be resolved through discussion.
Each of the non-rejected records will be assessed by at least two of
the reviewers to see if they are likely to meet the inclusion criteria
and full copies of reprints will be obtained for these reports. Each
of the full reports will then be assessed by at least two reviewers to
determine if they meet the inclusion criteria for the review. Any
disagreements will be resolved through discussion.
Assessment of methodological quality
The following criteria will be used to assess the methodological
quality of included studies:
1. Was there an inception cohort?
Yes = a complete sample of clinical trials registered at onset during
a specified period of time
No = anything else
Unclear
2. Was there complete follow-up (after data analysis) of all of the
trials in the cohort for at least four years?
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Yes > 90%
No < 90%
Unclear
3.Was publication ascertained through personal contact with the
investigators?
Yes =personal contactwith investigators, or searching the literature
and personal contact with investigator
No = searching the literature only
Unclear
4.Was positive and negative clearly defined and based on the
primary outcome(s) as defined by the investigators (prior to
obtaining results)?
Yes = clearly defined and based on primary outcomes in trial
protocols
No = not clearly defined or not based on primary outcomes in trial
protocols
Unclear
5.Were other possible confounders controlled for in the analysis,
including: sample size, duration, multi-centre versus single centre,
funding (external versus internal, industry funded versus other),
and investigator rank and were trials grouped for common
treatment comparisons?
Yes = two or more of the above.
No = one or none
Unclear
Overall quality of the studies will be summarised as “good” if all
of the above criteria are met, “moderate” (all but one met) and
“possibly problematic” (two or more not met).
Data extraction
Two reviewers (KLO and SH) will independently extract data.
Differences in data extraction will be resolved by discussion. The
reviewers will contact investigators to obtain information or data
needed for the review that could not be found in published reports.
Data will be extracted on the following:
P value (< 0.05 versus > 0.05)
Direction of results (positive or negative) - as defined above
Magnitude of effect
Higher rating by the investigator on the importance of study results
versus lower rating. (However defined in the included studies)
Funding mechanism (external versus internal, and industry
funding versus other)
Actual sample size (< 100, 100-999, >999 or as defined in included
studies)
Multi or single centre trials
Primary investigator sex (male versus female) - first author
Primary investigator rank (e.g. professor, associate professor,
assistant professor, other) - first author
for the following outcomes:
full publication
other types of publication (e.g. grey literature, abstract,
presentation, language of publication)
We will also collect details regarding other characteristics of the
types of data (countries, institutions, registers, inclusion criteria for
trials), types of comparisons, outcome measures for the included
studies, and means and duration of follow-up for the trials in the
cohort.
Data analysis
The primary analyses will compare the publication rates and
time to publication for positive and negative studies based on p-
values (or as reported by the study). Publication rates and time
to publication will also be analysed for direction of effect and
magnitude of effect. If possible, the analyses will be conducted
using raw data in Review Manager using relative risks (Mantel-
Haensel method). If the p-value for the chi-square test for
heterogeneity is > 0.10 we will summarise the overall relative risk
using the fixed effect model (Mantel-Haensel method). If there is
significant heterogeneity (p < 0.10) we will consider the following
possible explanations in subgroup analyses:
Length of follow-up
Overall quality of the studies
Adjusted for confounders
Time to publication will be analysed in the same way using
weighted means. If possible, secondary analyses will compare
pooled adjusted odds ratios to pooled un-adjusted odds ratios
(OR) for studies for which adjusted ORs can be obtained. We
will also compare time to publication controlling for confounders
and time to publication without controlling for confounders.
The possibility of publication bias for our included studies of
publication bias will be investigated using the Funnel plot.
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